Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients
- 27 November 2001
- Vol. 92 (11), 2927-2932
- https://doi.org/10.1002/1097-0142(20011201)92:11<2927::aid-cncr10109>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumoursBritish Journal of Cancer, 1999
- Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbationJournal of Medical Virology, 1997
- Biologic Properties of Hepatitis B Viral Genomes with Mutations in the Precore Promoter and Precore Open Reading FrameVirology, 1997
- Reduced Precore Transcription and Enhanced Core-Pregenome Transcription of Hepatitis B Virus DNA after Replacement of the Precore-Core Promoter with Sequences Associated with e Antigen-Seronegative Persistent InfectionsVirology, 1996
- Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatmentDigestive Diseases and Sciences, 1992
- Precore mutant hepatitis B virus infection and liver diseaseGastroenterology, 1992
- Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe HepatitisNew England Journal of Medicine, 1991
- MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1989
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Incidence of Hepatitis B Virus Infections in Preschool Children in TaiwanThe Journal of Infectious Diseases, 1982